Estefan Roy
Internal Medicine · Chicago, ILNPI 1457430852
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,170 and has fallen 96.9% since, to $66 in 2022. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 245 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$683
- Novo Nordisk$533
- Pfizer$440
- AstraZeneca$360
- Lilly USA, LLC$322
- AbbVie$317
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,617100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 26 | $683 |
| Novo Nordisk | 25 | $533 |
| Pfizer | 25 | $440 |
| AstraZeneca | 22 | $360 |
| Lilly USA, LLC | 16 | $322 |
| AbbVie(2 entities) | 18 | $317 |
| Johnson & Johnson | 13 | $301 |
| Amgen(2 entities) | 14 | $222 |
| GSK | 9 | $158 |
| Hikma Pharmaceuticals USA | 9 | $151 |
| Amarin Pharma, Inc. | 8 | $144 |
| Merck | 9 | $131 |
| Mylan Specialty L.p. | 6 | $105 |
| Sunovion Pharmaceuticals Inc. | 7 | $96 |
| Kowa Pharmaceuticals America, Inc. | 4 | $81 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| Sanofi-aventis U.S. LLC | 4 | $70 |
| Ironwood Pharmaceuticals, Inc | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Novartis | 2 | $39 |
| Dexcom, Inc. | 1 | $35 |
| Zyla Life Sciences, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Bayer | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$4,629 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.
Other internal medicine in Chicago
- Merle DiamondChicago$1.1M
- Robert KushnerChicago$516K
- Romeo UrsuaChicago$420K
- Peter O DonnellChicago$318K
- George UrbanChicago$258K
- Kristen PallokChicago$256K
- George NissanChicago$252K
- Luke LaffinChicago$162K
- Daniel CatenacciChicago$161K
- Hiren ShahChicago$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.